Comment from Yale Collaboration for Regulatory Rigor Integrity, and Transparency (CRRIT)

Summary: The Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT) argues that the FDA should sunset the Commissioner’s National Priority Voucher (CNPV) pilot program. They contend that the program is redundant with existing expedited pathways, lacks transparency in its selection process, and may compromise patient safety by prioritizing speed over rigorous scientific review.